Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Carcinoma; Endometrial Neoplasms; Melanoma; Pancreatic Neoplasms; Triple Negative Breast Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Breast Neoplasms; Triple Negative Breast Neoplasms | Phase 2 | ClinicalTrials |
| Melanoma | Phase 1/Phase 2 | ClinicalTrials |
| Breast Neoplasms; Triple Negative Breast Neoplasms | Phase 1 | ClinicalTrials |
| Stomach Neoplasms | Phase 2 | ClinicalTrials |
| Bone Marrow Diseases; Bone Neoplasms; Neoplasm Metastasis; Neoplasms, Second Primary; Prostatic Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Breast Neoplasms | Phase 1 | ClinicalTrials |
| Giant Cell Tumor of Tendon Sheath; Giant Cell Tumors; Neoplasms; Synovitis; Synovitis, Pigmented Villonodular | Phase 2 | ClinicalTrials |
CONTENTS